Search Results
Found 3 results
510(k) Data Aggregation
(246 days)
The Neurovascular Access System Family is indicated for the introduction of interventional devices into the peripheral and neuro vasculature. It is not intended for use in coronary arteries.
The subject Neurovascular Access System Family consists of sterile, single-use catheters and accessories that are used together to facilitate the insertion and guidance of an appropriately sized interventional device into a selected vessel in the peripheral and neurovasculature. The Neurovascular Access System is comprised of the Neurovascular Access Catheter, Access Tool, Peel Away Introducer and Dilator. The Neurovascular Access System Family is offered in various lengths to accommodate physician preferences and anatomical variations. The distal end of the catheter is coated with hydrophilic coating to reduce friction during use and a radiopaque marker on the distal tip that is visible under fluoroscopy.
This document is a 510(k) Summary for a medical device called the "Neurovascular Access System Family." It details the device's characteristics, intended use, and compares it to legally marketed predicate devices to demonstrate substantial equivalence.
Here's a breakdown of the requested information based on the provided text:
1. A table of acceptance criteria and the reported device performance
| Test Name | Objective | Test Method / Standard or Guidance | Acceptance Criteria (Implied by "Pass") | Reported Device Performance |
|---|---|---|---|---|
| Visual Surface Requirements | To demonstrate that the device meets the visual surface requirements. | ISO 10555-1 2013, Section 4.4 | Device meets visual surface requirements. | Pass |
| Dimensional Verification | To demonstrate that the device meets the dimensional requirements. | ISO 10555-1 2013, Section 4.5 | Device meets dimensional requirements. | Pass |
| Liquid Leakage Under Pressure | To demonstrate that the device passes the liquid leakage under pressure test. | ISO 10555-1 2013, Section 4.7.1, Annex C | Device passes liquid leakage test. | Pass |
| Hub Aspiration Air Leakage | To demonstrate that the device passes the hub aspiration air leakage test. | ISO 10555-1 2013, Section 4.7.2, Annex D | Device passes hub aspiration test. | Pass |
| Simulated Use and Usability | To demonstrate that the device passes testing specified in the simulated use test protocol. Simulated use testing includes usability assessment with multiple physicians. | FDA guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions", April 2023 | Device passes simulated use and usability protocols. | Pass |
| Flex Fatigue | To demonstrate that the device passes the flex fatigue test. | FDA guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions", April 2023 | Device passes flex fatigue test. | Pass |
| Torque Test | To demonstrate the torque strength of the device. | FDA guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions" April 2023 | Device demonstrates adequate torque strength. | Pass |
| Tip Deflection | To demonstrate that the tip deflection is comparable to the predicate device. | FDA Guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions" April 2023 | Tip deflection is comparable to predicate. | Pass |
| Device Removal Forces | To demonstrate that the removal forces are comparable to the predicate device. | FDA Guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions" April 2023 | Removal forces are comparable to predicate. | Pass |
| Peak Tensile Strength Testing | To demonstrate that the device passes the peak tensile strength testing including all bonds and joints. | ISO 10555-1 2013, Section 4.6, Annex B | Device passes peak tensile strength testing. | Pass |
| Flow Rate | To demonstrate that the flow rate is comparable to the predicate device. | ISO 10555-1 2013: Section 4.9 | Flow rate is comparable to predicate. | Pass |
| Corrosion Resistance | To demonstrate that the device has no visual evidence of corrosion. | ISO 10555-1 2013, Section 4.5, Annex A | No visual evidence of corrosion. | Pass |
| Radiopacity | To demonstrate that the distal marker band is clearly visible under typical fluoroscopic imaging conditions. | ISO 10555-1 2013, Section 4.2; ASTM F640-12 | Distal marker band is clearly visible. | Pass |
| Kink Resistance | To demonstrate that shaft kink resistance is comparable to the predicate device and clinically relevant for the intended anatomical locations for use. | FDA Guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions" | Shaft kink resistance is comparable to predicate and clinically relevant. | Pass |
| Particulates and Coating Integrity | To demonstrate the quantity and size of particles generated during simulated use are comparable to the predicates and reference devices. | FDA Guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions" | Particulates and coating integrity are comparable to predicates. | Pass |
| Dynamic Burst | To demonstrate that the device withstands dynamic burst strength. | ISO 10555-1 2103, Annex G | Device withstands dynamic burst strength. | Pass |
| Static Burst | To demonstrate that the device passes static burst pressure as specified in the test protocol. | ISO 10555-1 2013, Section F | Device passes static burst pressure. | Pass |
| Shelf Life | Repeated bench tests after accelerated aging to demonstrate that the device performance is maintained over the proposed shelf-life (6 months). | ASTM D4332-22, ASTM D4169-22, ASTM F1980-21, ASTM F1886 / F1866M-16, ASTM 2096-11 (2019), ASTM F88/F88M:21 | Device performance maintained over 6-month shelf-life. | Pass |
Biocompatibility Tests:
| Test Name | Objective (Implied) | Test Method / Standard or Guidance | Acceptance Criteria (Implied by "Results") | Reported Device Performance |
|---|---|---|---|---|
| Cytotoxicity | Assess cell toxicity. | ISO 10993-5 | No reactivity observed. | Non-cytotoxic |
| Sensitization | Assess potential for allergic reactions. | ISO10993-10 | No evidence of delayed dermal contact sensitization. | Non-sensitizing |
| Intracutaneous Reactivity | Assess localized irritation. | ISO 10993-23 | Scores from test article extracts were acceptable (<1.0 for sesame seed oil). | Non-irritant |
| Acute Systemic Toxicity | Assess systemic toxic effects. | ISO 10993-11 | No mortality or evidence of systemic toxicity. | Non-toxic |
| Material Mediated Pyrogenicity | Assess fever-inducing substances. | ISO 10993-11 | No rabbit temperature rise ≥ 0.5 °C. | Non-pyrogenic |
| Hemolysis - Direct Contact and Extract Method | Assess red blood cell damage. | ISO 10993-4 | Mean blank corrected % hemolysis < 2%. | Non-hemolytic |
| Complement Activation | Assess immune system activation. | ISO 10993-4 | Results within acceptable range compared to controls. | Not a Sc5b-9 complement activator |
| Thrombogenicity | Assess potential for blood clot formation. | ISO 10993-4 | No adverse effects/clinical signs, no thrombus score ≥ 2, similar to comparator/negative controls in PTT and platelet/leukocyte counts. | Non-thrombogenic |
Sterility Testing:
| Test Name | Objective (Implied) | Test Method / Standard or Guidance | Acceptance Criteria | Reported Device Performance |
|---|---|---|---|---|
| Sterilization Validation | Ensure device is sterile. | ISO 11135:2014 | Sterility Assurance Level (SAL) of 1x10⁻⁶ achieved. | Pass |
| EO and ECH Residuals | Ensure residuals are below toxic levels. | ISO 10993-7:2008 | Residuals below specified limits. | Pass |
| Bacterial Endotoxin Levels | Ensure endotoxin levels are safe. | FDA's sterility guidance | Levels below 2.15 EU/device. | Pass |
| Shelf-Life (Sterility) | Maintain sterility over proposed shelf-life. | (Implicitly part of validation) | Sterility maintained over 6 months. | Pass |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document lists "Performance Data" in Section VII and "Biocompatibility" in Section VIII.
- Performance Data: The specific sample sizes for each performance test (e.g., visual, dimensional, burst, fatigue) are not explicitly stated in this summary table. The document only indicates "Pass" for each test. The methods refer to ISO standards and FDA guidance documents, which typically define appropriate sample sizes for such tests.
- Biocompatibility Data: Similarly, the sample sizes for the various biocompatibility tests (e.g., number of cells, animals for in vivo tests) are not explicitly stated.
- Data Provenance: The document does not provide information on the country of origin of the data or whether the studies were retrospective or prospective. These are typically bench and laboratory tests performed by the manufacturer or contract labs.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- For the "Simulated Use and Usability" test, the objective states an "usability assessment with multiple physicians." The exact number of physicians and their specific qualifications are not provided in this summary.
- For all other tests, ground truth is established by objective measurements against specified standards (ISO, ASTM, FDA guidance), rather than expert consensus on images or outcomes. Therefore, "experts" in the sense of clinical reviewers establishing ground truth for diagnostic accuracy are not applicable here.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. This device is an access catheter, and the performance criteria are based on engineering, mechanical, and biological testing, not on interpretation of clinical data requiring adjudication by experts.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is a medical device (catheter), not an AI diagnostic algorithm. Therefore, MRMC studies and the concept of human readers improving with AI assistance are not relevant to this submission.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable. This is a medical device (catheter), not an algorithm or AI system.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
The ground truth for this device's performance testing is based on:
- Established Industry Standards: ISO 10555-1, ISO 10993 series, ASTM standards.
- FDA Guidance Documents: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions."
- Objective Measurements: Such as dimensional measurements, pressure thresholds, tensile strength, flow rates, visual inspection for corrosion or particulates, and biological responses in biocompatibility tests.
- Simulated Use: Involving usability assessment (implied to be clinical feedback from physicians during simulated use).
Essentially, the ground truth is adherence to predefined physical, chemical, mechanical, and biological specifications and performance metrics.
8. The sample size for the training set
Not applicable. This is a medical device, not a machine learning model that requires training data.
9. How the ground truth for the training set was established
Not applicable. There is no training set for this type of medical device submission.
Ask a specific question about this device
(344 days)
072 Aspiration Catheter: As part of the 072 Aspiration System, the 072 Aspiration Catheter with a compatible suction pump is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA therapy are candidates for treatment.
Aspiration Tubing: As part of the 072 Aspiration System, the Aspiration Tubing is intended to connect the 072 Aspiration Catheter to a compatible suction pump.
The 072 Aspiration Catheter is a single lumen, variable stiffness catheter. The catheter has a hydrophilic coating to reduce friction during use. The catheter includes radiopaque markers on the distal end for angiographic visualization and a Luer hub on the proximal end allowing attachments for flushing and aspiration. The Delivery Tool is an optional accessory for use with the 072 Aspiration Catheter and should be removed prior to aspiration. The 072 Aspiration Catheter, Delivery Tool. Rotating Hemostasis Valve, and Flow Switch are included in the package. The Aspiration Tubing is provided in a separate package. For the aspiration source, the 072 Aspiration Catheter is used in conjunction with a compatible suction pump with prespecified performance parameters that is connected using the Aspiration Tubing.
Here's a breakdown of the acceptance criteria and study information for the Q'Apel Medical, Inc. 072 Aspiration System, based on the provided document:
1. Table of Acceptance Criteria and Reported Device Performance
The acceptance criteria are generally phrased as meeting "predetermined acceptance criteria" or specific ISO standards. The reported device performance for all bench tests and animal studies is "Pass," indicating that all samples met the defined criteria.
Note: For bench tests, specific numerical acceptance criteria are not detailed in the provided summary, only the general statement that "All samples met the predetermined acceptance criteria." For biocompatibility, the specific numerical acceptance criteria are listed.
| Test Category | Acceptance Criteria (as stated) | Reported Device Performance |
|---|---|---|
| Bench Testing | ||
| Visual Surface Requirement | Device meets visual surface requirements. | Pass |
| Packaging Visual Inspection | Packaging meets visual inspection. | Pass |
| Dimensional/Visual Inspection | Device dimensions conform to specifications. | Pass |
| Liquid Leakage Under Pressure | Catheter joint strength meets freedom from leakage requirements of ISO 10555-1:2013, Annex C. | Pass |
| Hub Aspiration Air Leakage | Device passes hub aspiration air leakage test of ISO 10555-1:2013, Annex D. | Pass |
| Simulated Use | Effectiveness of device at retrieval of soft and firm clots and mechanical integrity after multiple passes. | Pass |
| Flex Fatigue | Meets minimum value per specification for multiple passes in the simulated use model. | Pass |
| Track and Advance Force | Test specimens meet track and advance force criteria. | Pass |
| Tip Deflection | Test specimens meet tip deflection forces criteria and compare favorably to predicate catheters. | Pass |
| Torque | Number of revolutions to failure of the Catheter in simulated anatomy meets criteria. | Pass |
| Tip Elongation and Compression | Test specimens meet tip elongation and compression criteria. | Pass |
| Peak Tensile | Tensile strength of catheter sections and bonds meets criteria after simulated use. | Pass |
| Particulates, Coating Integrity | Integrity of hydrophilic coating evaluated after multiple insertion/withdrawal cycles, and particulates measured during simulated use compared to reference device, meet criteria. | Pass |
| Flow Rate | Flow rate through a catheter meets ISO 10555-1, Annex E. | Pass |
| Aspiration Flow Rate | Aspiration flow rate through the aspiration catheter meets criteria when connected to a constant vacuum source. | Pass |
| Kink Resistance | Test specimen segments formed into a defined bend diameter meet kink resistance criteria. | Pass |
| Corrosion Resistance | No visible corrosion immediately after Corrosion Testing procedure based on ISO 10555-1, Annex A. | Pass |
| Radiopacity | Marker band is fluoroscopically visible. | Pass |
| Burst Pressure-Static | Tested per ISO 10555-1:2013, Annex F, after simulated use, meets criteria. | Pass |
| Burst Pressure-Dynamic | Minimum value per specification. | Pass |
| Connectors for Intravascular | Hubs tested per ISO 80369-7. | Pass |
| Lumen Collapse | Aspiration Catheter samples meet lumen patency under maximum applied vacuum pressures. | Pass |
| Manual Syringe Injection Peak Pressure | Measure peak pressure during manual injection of contrast media with a syringe, meets criteria. | Pass |
| Aspiration Tubing Bench Testing | ||
| Dimensional/Visual Inspection | Aspiration Tubing meets all dimensional and visual specifications. | Pass |
| Tensile Strength | Aspiration Tubing meets existing tensile strength specifications. | Pass |
| Simulated Use Test | Aspiration Tubing passes testing specified in the simulated use test protocol. | Pass |
| Resistance to Collapse and Leakage at Maximum Aspiration Pressures | Aspiration Tubing resistance to collapse at maximum aspiration pressure meets testing specified in the test protocol and does not show signs of leakage at maximum aspiration pressure. | Pass |
| Flow Switch Functionality Testing | Flow Control Switch completely and immediately stops fluid flow after a specified number of ON/OFF cycles. | Pass |
| Biocompatibility Testing (072 Aspiration Catheter and Delivery Tool) | ||
| Cytotoxicity - MEM Elution | The achievement of a numerical grade greater than 2 is considered a cytotoxic effect. (Implicit acceptance: numerical grade ≤ 2) | Non-cytotoxic |
| Sensitization | Magnusson and Kligman grades of 1 or greater in the test group generally indicate sensitization, provided grades of less than 1 are seen in control animals. If grades of 1 or greater are noted in control animals, then the reactions of test animals which exceed the most severe reaction in control animals are presumed to be due to sensitization. (Implicit acceptance: no statistically significant sensitization compared to control) | Non-sensitizing |
| Irritation: Intracutaneous Reactivity | The requirements of the test were met if the final test article score was ≤ 1.0. | Non-irritating |
| Acute Systemic Toxicity | If using five animals per group, the test article meets the requirement of the test if: 1. Two or more animals from the test group die. 2. Animal behavior, such as convulsions or prostration, occurs in two or more animals from the test group. 3. A final (end of study) body weight loss > 10% occurs in three or more animals from the test group. (Implicit acceptance: none of these conditions occurred) | Non-toxic |
| Material Mediated Pyrogenicity | The requirements of the test were met if no rabbit showed an individual rise in temperature of 0.5 °C or more above its respective baseline temperature throughout the duration of the test. | Non-pyrogenic |
| ASTM Hemolysis- Direct | The positive control's mean hemolytic index above the negative control must be ≥ 5% for the direct method. The negative control must display a mean hemolytic index of < 2% for the direct method. (Implicit acceptance: test article meets non-hemolytic criteria based on these controls) | Non-hemolytic for the Direct Method |
| ASTM Hemolysis- Indirect | The positive control's mean hemolytic index above the negative control must be ≥ 5% for the indirect method. The negative control must display a mean hemolytic index of < 2% for the indirect method. (Implicit acceptance: test article meets non-hemolytic criteria based on these controls) | Non-hemolytic for the Indirect Method |
| Hemocompatibility- Complement Activation | The negative control (HDPE) concentration must not be significantly higher when compared to the NHS at 37 °C concentration or the final concentration must fall within ± 1 standard deviation of the mean in the test facility historical range for HDPE. The positive reference control (Latex) concentration must be statistically significant when compared to the NHS at 37 °C concentration or the final concentration must fall within ± 1 standard deviation of the mean in the test facility historical range for Latex. (Implicit acceptance: test article acts like negative control) | Non-activator of the Complement System |
| Thrombogenicity | The thrombogenic potential of a blood-contacting medical device must be comparable to a predicate device. (Implicit acceptance: comparable to predicate device) | Non-thrombogenic |
| Biocompatibility Testing (Aspiration Tubing) | ||
| Cytotoxicity - MEM Elution | The achievement of a numerical grade greater than 2 is considered a cytotoxic effect. (Implicit acceptance: numerical grade ≤ 2) | Non-cytotoxic |
| Sensitization | Test group shall yield Grade < 1 score on Magnusson and Kligman scale (provided control group yields Grade < 1). (Implicit acceptance: Grade < 1) | Non-sensitizer |
| Irritation: Intracutaneous Reactivity | The test requirements are met if the difference between the test mean score and the control mean score is 1.0 or less and the test does not fail at any observation period. Differences of less than 0 are reported as 0. (Implicit acceptance: difference < 1.0) | Non-irritant |
2. Sample Size Used for the Test Set and Data Provenance
- Bench Testing: The document consistently states "All samples met the predetermined acceptance criteria" for each bench test. However, the exact numerical sample size for each specific bench test is not provided.
- Animal Study: The study involved a "porcine model." The exact number of animals used is not specified. The study was conducted "according to Good Laboratory Practices (GLP) per 21 CFR Part 58," which indicates controlled experimental conditions.
- Data Provenance:
- Bench Testing: In-house testing by Q'Apel Medical, Inc.
- Animal Study: Experimental, prospective study in a porcine (animal) model.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
- Bench Testing: Not applicable in the context of expert ground truth. These tests likely involved technicians or engineers following standardized protocols.
- Animal Study: The document doesn't specify the number or qualifications of experts (e.g., veterinarians, pathologists) involved in establishing ground truth (e.g., assessing vessel histology or clot aspiration results). It mentions that "Sub-chronic and chronic time points were assessed" and that "Clot aspiration and wedge assessment were comparable between the test and control catheters, and both were shown to be safe in porcine vessels via angiography and vessel histology." This implies expert assessment of the outcomes, but details are absent.
4. Adjudication Method for the Test Set
- Bench Testing: Not applicable. Bench tests typically rely on objective measurements against predefined specifications.
- Animal Study: Not specified. While the results were declared "comparable" and "safe," it's not explicitly stated if multiple experts reviewed the outcomes and how any discrepancies were resolved.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
- No. A Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. The document explicitly states: "No clinical study was conducted as bench and animal testing was determined sufficient for verification and validation purposes and to support the substantial equivalence of the 072 Aspiration System." Therefore, there is no effect size reported for human readers with and without AI assistance.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done
- Not applicable. The device is a physical medical instrument (an aspiration catheter system), not an AI algorithm. Therefore, "standalone" performance in the context of an algorithm is not relevant. The performance reviewed is the device's physical function.
7. The Type of Ground Truth Used
- Bench Testing: Reference standards (e.g., ISO standards), design specifications, and comparison to a reference device (K211564 for simulated use particulates) were used to establish "ground truth" (i.e., expected performance).
- Animal Study: Angiography and vessel histology were used as ground truth for assessing safety and effectiveness (clot aspiration, wedge assessment, tissue response) in the porcine model. These are objective measures collected during and after the animal procedures.
8. The Sample Size for the Training Set
- Not applicable. This device is a physical medical instrument, not a machine learning or AI algorithm. Therefore, there is no "training set" in the context of data used to train an AI model.
9. How the Ground Truth for the Training Set was Established
- Not applicable. As stated above, this is not an AI device, so there is no training set or ground truth for a training set.
Ask a specific question about this device
(136 days)
The SelectFlex Neurovascular Access System Family is indicated for the introduction of interventional devices into the peripheral and neurovasculature.
The subject SelectFlex Neurovascular Access System Family is a line extension to expand the previously cleared device (K211893) by offering a new SelectFlex III 064 Neurovascular Access Catheter with a diameter of 6F, a 6F dilator, an introducer sheath, and a 4.5F Access Tool that can be used with the catheter to access the desired anatomy. The 4.5F Access Tool is an accessory provided with the SelectFlex III 064 Neurovascular Access Catheter and is packaged in the same sterile pouch with the SelectFlex III 064 Neurovascular Access Catheter and accessories as part of the SelectFlex Neurovascular Access System Family.
The provided text is a 510(k) Summary for a medical device (SelectFlex Neurovascular Access System Family) and does not describe a study that proves the device meets specific acceptance criteria in the context of an AI/human-in-the-loop diagnostic system. Instead, it describes nonclinical performance testing (bench testing) and biocompatibility testing conducted to demonstrate substantial equivalence to a legally marketed predicate device.
Therefore, many of the requested items (e.g., sample sized for the test set in an AI study, number of experts for ground truth, MRMC study, standalone performance, training set details) are not applicable to this document.
However, I can extract the acceptance criteria (goals) and reported performance (results) from the nonclinical performance data section.
Here's the information based on the provided text:
1. A table of acceptance criteria and the reported device performance
For the SelectFlex Neurovascular Access System Family (including the SelectFlex III 064 Neurovascular Access Catheter, 6F Dilator, and 4.5F Access Tool where applicable):
| Test Name | Acceptance Criteria (Goal) | Reported Device Performance (Result) |
|---|---|---|
| Visual Surface Requirements | To demonstrate that the device meets the visual surface requirements. | Pass: All samples met the predetermined acceptance criteria. |
| Dimensional Verification | To demonstrate that the device meets the dimensional requirements. | Pass: All samples met the predetermined acceptance criteria. |
| Liquid Leakage Under Pressure | To demonstrate that the device passes the liquid leakage under pressure test. | Pass: All samples met the predetermined acceptance criteria. |
| Hub Aspiration Air Leakage | To demonstrate that the device passes the hub aspiration air leakage test. | Pass: All samples met the predetermined acceptance criteria. |
| Simulated Use/Usability | To demonstrate that the device passes testing specified in the simulated use test protocol. Simulated use testing includes usability assessment with multiple physicians. | Pass: All samples met the predetermined acceptance criteria. |
| Flex Fatigue | To demonstrate that the device passes the flex fatigue test. | Pass: All samples met the predetermined acceptance criteria. |
| Inflation Fatigue | To demonstrate that the device passes the inflation fatigue test. | Pass: All samples met the predetermined acceptance criteria. |
| Burst Volume | To demonstrate that the device passes the burst volume test – tested to 2x the inflation volume. | Pass: All samples met the predetermined acceptance criteria. |
| Torque Test | To demonstrate the device's ability to rotate 720 degrees (2 full revolutions) at the proximal end. | Pass: All samples met the predetermined acceptance criteria. |
| Tip Deflection | To demonstrate that the tip deflection is comparable to the predicate device. | Pass: All samples met the predetermined acceptance criteria. |
| Device Removal in Support and Tracking Modes | To demonstrate that the forces in both support and tracking modes are comparable to the predicate device. | Pass: All samples met the predetermined acceptance criteria. |
| Peak Tensile Testing | To demonstrate that the device passes the peak tensile strength testing including all bonds and joints. | Pass: All samples met the predetermined acceptance criteria. |
| Flow Rate | To demonstrate that the flow rate is comparable to the predicate device. | Pass: All samples met the predetermined acceptance criteria. |
| Corrosion Resistance | To demonstrate that the device has no visual evidence of corrosion. | Pass: All samples met the predetermined acceptance criteria. |
| Radiopacity | To demonstrate that the marker band is positioned at the distal tip of the catheter and is clearly visible under typical fluoroscopic imaging conditions. | Pass: All samples met the predetermined acceptance criteria. |
| Particulates, Coating Integrity, Lubricity, Durability | To demonstrate the quantity and size of particles generated during simulated use are comparable to the predicate and reference devices. | Pass: All samples met the predetermined acceptance criteria. |
| Static Burst | To demonstrate that the device passes static burst as specified in the test protocol. | Pass: All samples met the predetermined acceptance criteria. |
| Shelf Life | To demonstrate that the device performance is maintained over the proposed shelf-life (6 months). | Pass: All samples met the predetermined acceptance criteria. |
Biocompatibility Testing:
| Test Name | Acceptance Criteria (Goal) | Reported Device Performance (Result) | Conclusion |
|---|---|---|---|
| Cytotoxicity | Absence of reactivity | No reactivity was observed with the test article at 24 and 48 hours. | Non-cytotoxic |
| Sensitization | No evidence of sensitization | The test article extracts showed no evidence of delayed dermal contact sensitization in the guinea pig maximization test. | Non-sensitizing |
| Intracutaneous Reactivity | No irritation | The scores from test article extracts were 0 from the saline extract and 0 from the sesame seed oil extract. | Non-irritant |
| Acute Systemic Toxicity | No abnormal clinical signs/toxicity | No abnormal clinical signs indicative of toxicity were observed for 72 hours. All animals were alive at the end of 72 hours and body weight changes were within acceptable parameters. | Non-toxic |
| Material Mediated Pyrogenicity | No significant temperature rise | No rabbit temperature rise ≥ 0.5 °C. | Non-pyrogenic |
| Hemolysis - Direct Contact and Extract Method | Non-hemolytic | Blank corrected hemolytic index: 0.15, 0.13. | Non-hemolytic |
| Complement Activation | Results within acceptable range | Results within acceptable range as compared to the controls. | Not a Sc5b-9 complement activator |
| Thrombogenicity | No adverse effects/thrombus | No adverse effects or clinical signs during test period and no thrombus score ≥ 2 for either test or control device. | Non-thrombogenic |
2. Sample sized used for the test set and the data provenance
The document does not specify sample sizes for each particular test, only stating "All samples" or providing a conclusion based on the samples tested. The data provenance is "bench testing" and "biocompatibility testing," which are laboratory-based tests of the device itself, not clinical data or data from human subjects.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. This is a medical device performance and biocompatibility study, not an AI diagnostic study relying on expert ground truth. However, for "Simulated Use/Usability," it states "usability assessment with multiple physicians," but specific numbers or qualifications are not provided.
4. Adjudication method for the test set
Not applicable.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. No AI component is mentioned.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
Not applicable. No AI component is mentioned.
7. The type of ground truth used
For nonclinical performance, the "ground truth" is defined by established engineering and material science standards (e.g., ISO 10555-1, FDA guidance documents, ASTM D4332, AAMI TIR42, ISO 10993 series for biocompatibility). The device's physical properties and interactions are measured against these objective criteria.
8. The sample size for the training set
Not applicable. There is no AI training set as this is a device performance study.
9. How the ground truth for the training set was established
Not applicable. There is no AI training set.
Ask a specific question about this device
Page 1 of 1